Target Corporation Filed: September 22, 2020 1:20-cv-07818 A case claims Target charges more for the infants version of its Up&Up-brand acetaminophen than its childrens counterpart when the products are exactly the same. New York A proposed class action claims Target Corporation charges more for the infants version of its Up&Up-brand acetaminophen than its childrens counterpart even though the pain-relieving products are otherwise exactly the same. According to the case out of New York, Target has misleadingly marketed the two over-the-counter productsUp&Up Dye-Free Acetaminophen Fever Reducer/Pain Reliever Liquidas appropriate for different ages in order to deceive parents and caregivers into paying a higher price for the infants medication despite the fact that the pain relievers contain the same exact amount of acetaminophen in the same dosage amounts. Defendants advertisements, marketing representations, and placement of the Product in its stores are misleading, untrue, and likely to deceive reasonable consumers, the complaint scathes, arguing that no reasonable consumer would pay twice as much for an infants medication over a childrens product unless they were deceived into thinking infants cannot safely take childrens medications

This combination of essential B vitamins helps reduce fatigue, improve metabolism, and maintain healthy body functions
Interestingly, a couple of Parkinsons drugs are derived from ergot
Add in roughly a dozen tendons, multiple ligaments, the median nerve, and various blood vessels all packed into a compact space, and you begin to see why wrist problems are so prevalent